| 763918 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.587 |
El-Hajjar Mikal, Gerhardt Lara, Krishnamoorthy Mithunah, Figueredo Rene, Zheng Xiufen, Koropatnick James, Maleki Saman |
| 763917 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.547 |
Haydon Andrew, Alamgeer Muhammad, Brungs Daniel, Collichio Frances, Khushalani Nikhil, Colevas Dimitrios, Rischin Danny, Kudchadkar Ragini, Chai-Ho Wanxing, Daniels Gregory, Lutzky Jose, Lee Jenny, Bowyer Samantha, Migden Michael, Silk Ann, Lebbe Celeste, Grob Jean-jaques, Melero Ignacio, Sheladia Piyush, Bommareddy Praveen, He Shui, Andreu-Vieyra Claudia, Fury Matthew, Hill Andrew |
| 763916 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
58 Analytical validation of a novel immunohistochemistry assay to determine nuclear AHR expression in human bladder cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.058 |
Wang Lei, Sanchez-Martin Marta, Tirrell Steve, Ortiz-Otero Nerymar, Zhang Michelle |
| 763915 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
226 Neoantigen-specific TCR-T cells targeting shared hotspot mutations for adoptive cell therapy in common epithelial cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.226 |
Korngold Ana, Yong Lin-Kin, Ibekwe Ugochi, Simmons Julissa, Eckels Phillip, Figueroa Elizabeth, Hotard Michelle, Adeyemi Frances, Hunt Thomas, Markus Tegan, Hurton Lenka, Shi Yaoyao, Collinson-Pautz Matthew, Balasubramanian Priya, Wang Cathy, Andersson Jourdan, Heese Lauren, Khalil Mariam, Torres David, Olivares Emarco, Bardelli Geraldine, O’Brien Kelly, Hashmi Haroon, Chekmasova Alena, Baffa Raffaele, Spencer Tom, Groot Eleanor De, Deniger Drew |
| 763914 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
762 STING agonism combined with arginase, NOS2, and PTGES/COX2 inhibitors for improved anti-tumor immunotherapeutic benefit |
2021-11-01 |
10.1136/jitc-2021-sitc2021.762 |
Filderman Jessica, Chelvanambi Manoj, Storkus Walter |
| 763913 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
300 Longitudinal plasma proteomic profiling of non-small cell lung cancer patients undergoing immune checkpoint blockade-based therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.300 |
Harel Michal, Lahav Coren, Jacob Eyal, Sela Itamar, Elon Yehonatan, Yahalom Galit, Kamer Iris, Sharon Ofer, Shaked Yuval, Dicker Adam, Carbone David, Bar Jair |
| 763912 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
181 Intraepithelial group 1 innate lymphoid cells generated in vitro exhibit enhanced cytotoxicity and infiltration into solid tumoroids |
2021-11-01 |
10.1136/jitc-2021-sitc2021.181 |
Horowitz Nina, Hickey John, Sunwoo John |
| 763911 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation |
2021-11-01 |
10.1136/jitc-2021-sitc2021.396 |
Zhou Alice, Rettig Michael, Foltz Jennifer, Luo Jingqin, Butt Omar, Avvaru Chai, Katumba Ruth, Kim Albert, Dunn Gavin, Abraham Christopher, Yang Se Hwan, Fan Jean, Lee Byung Ha, Le NgocDiep, Ansstas George, Johanns Tanner, Huang Jiayi, Chheda Milan, Fehniger Todd, Campian Jian |
| 763910 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
360 Tumor-immune signatures associated with response or resistance to tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.360 |
Hsu Chiun, Edeline Julien, Masi Gianluca, Ma Yuk Ting, Wang Weilin, Wege Henning, Fei Cong, Ling Chen, Ma Xiaopeng, Zhang Pei, Huang Ruiqi, Wu Xikun, Shen Zhirong, Li Bai, Duque Sandra Chica, Meng Zhiqiang |
| 763909 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
429 Phase 1 dose escalation study of the agonist redirected checkpoint, SL-172154 (SIRPα-Fc-CD40L) in subjects with platinum-resistant ovarian cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.429 |
Lakhani Nehal, Richardson Debra, Kristedja Timothy, Rangwala Fatima, McKay Hannah, Gonzalez Louis, Ma Bo, Pandite Lini, Hamilton Erika |
